A detailed history of Advisor Group Holdings, Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 2,391 shares of GKOS stock, worth $374,263. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,391
Previous 9,536 74.93%
Holding current value
$374,263
Previous $1.13 Million 72.43%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$113.62 - $135.39 $811,814 - $967,361
-7,145 Reduced 74.93%
2,391 $311,000
Q2 2024

Aug 13, 2024

BUY
$89.48 - $118.35 $29,349 - $38,818
328 Added 3.56%
9,536 $1.13 Million
Q1 2024

May 10, 2024

SELL
$76.4 - $96.33 $99,014 - $124,843
-1,296 Reduced 12.34%
9,208 $868,000
Q4 2023

Feb 12, 2024

SELL
$59.53 - $85.11 $1.4 Million - $2 Million
-23,553 Reduced 69.16%
10,504 $834,000
Q3 2023

Nov 13, 2023

BUY
$69.23 - $79.09 $1.23 Million - $1.4 Million
17,713 Added 108.38%
34,057 $2.56 Million
Q2 2023

Aug 10, 2023

BUY
$45.44 - $71.21 $29,263 - $45,859
644 Added 4.1%
16,344 $1.16 Million
Q1 2023

May 12, 2023

BUY
$43.88 - $52.48 $78,896 - $94,359
1,798 Added 12.93%
15,700 $786,000
Q4 2022

Feb 10, 2023

SELL
$40.82 - $57.75 $14,287 - $20,212
-350 Reduced 2.46%
13,902 $607,000
Q3 2022

Nov 14, 2022

BUY
$46.84 - $58.49 $184,783 - $230,743
3,945 Added 38.27%
14,252 $758,000
Q2 2022

Aug 10, 2022

BUY
$34.86 - $63.77 $7,285 - $13,327
209 Added 2.07%
10,307 $468,000
Q1 2022

May 04, 2022

BUY
$44.33 - $57.82 $194,076 - $253,135
4,378 Added 76.54%
10,098 $585,000
Q3 2021

Nov 05, 2021

SELL
$47.43 - $84.23 $6,213 - $11,034
-131 Reduced 2.24%
5,720 $276,000
Q2 2021

Aug 02, 2021

BUY
$73.06 - $97.7 $117,188 - $156,710
1,604 Added 37.77%
5,851 $495,000
Q1 2021

May 13, 2021

BUY
$70.43 - $97.42 $18,593 - $25,718
264 Added 6.63%
4,247 $358,000
Q4 2020

Feb 10, 2021

SELL
$48.9 - $75.26 $103,325 - $159,024
-2,113 Reduced 34.66%
3,983 $301,000
Q3 2020

Nov 12, 2020

SELL
$37.23 - $50.97 $30,342 - $41,540
-815 Reduced 11.79%
6,096 $302,000
Q2 2020

Aug 14, 2020

SELL
$28.78 - $46.83 $65,273 - $106,210
-2,268 Reduced 24.71%
6,911 $265,000
Q1 2020

May 18, 2020

BUY
$25.53 - $70.14 $234,339 - $643,815
9,179 New
9,179 $283,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.45B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.